Andrew Kolodny

Senior Scientist

Andrew  Kolodny's photo


Office: Heller-Brown Building 261
Phone: 781 736-4542
Brandeis Directory


Dr. Andrew Kolodny is one of the nation's leading experts on the opioid crisis, including the following topics:

Epidemiology of Opioid Use Disorder
Treatment of Opioid Use Disorder
Public health responses to the opioid crisis
Practices and trends in use of opioid analgesics
Deceptive pharmaceutical marketing practices
Regulation of the opioid industry


Columbia University College of Physicians and Surgeons, New York, NY
Fellowship in Public Psychiatry (2003-2004)

Unites States Senate, Washington, DC
Daniel X Freedman Health Policy Fellowship (2003)

Mount Sinai School of Medicine, New York, NY
Internship & Residency in Psychiatry (1999-2003)


  • Temple University
  • Queens College, City University of New York

Andrew Kolodny

Senior Scientist


Dr. Andrew Kolodny is the Medical Director for the Opioid Policy Research Collaborative. He also serves as President of Physicians for Responsible Opioid Prescribing, an organization that advocates for more cautious opioid prescribing. He is one of the nation's leading experts on the opioid crisis. Dr. Kolodny has assisted Committees of the United States Senate and House of Representatives, the U.S. Department of Justice and state Attorneys General in their investigations of the opioid industry and pain organizations. He is currently serving as an expert witness in litigation by state governments against the opioid industry.

Dr. Kolodny previously served as Chief Medical Officer for Phoenix House, a national
nonprofit addiction treatment agency and Chair of Psychiatry at Maimonides Medical
Center in New York City. Dr. Kolodny has a long-standing interest in public health. He
began his career working for the New York City Department of Health and Mental
Hygiene in the Office of the Executive Deputy Commissioner. For New York City, he
helped develop and implement multiple programs to improve the health of New Yorkers
and save lives, including citywide buprenorphine programs, naloxone overdose
prevention programs and emergency room-based screening, brief intervention and
referral to treatment (SBIRT) programs for drug and alcohol misuse.

Dr. Kolodny's testimony before for the United States Congress is available here.

Senate Caucus on International Narcotics Control. May 14, 2014
America's Addiction to Opioids: Heroin and Prescription Drug Use

Homeland Security and Governmental Affairs. January 17, 2018
Unintended Consequences: Medicaid and the Opioid Epidemic

Committee on Energy & Commerce, Subcommittee on Health, U.S. House of Representatives. February 28, 2018
Combatting the Opioid Crisis

See the listing of Dr. Kolodny's publications on PubMed

Awards and Honors

  • University of Chicago Leon I. Goldberg Award (2019)


  • Kolodny, Andrew. "Assessment of Excess Mortality Associated With Drug Overdose in Ohio From 2009 to 2018." JAMA Network Open (2021).
  • Kolodny, Andrew. "How FDA Failures Contributed to the Opioid Crisis." AMA Journal of Ethics (2021).
  • Kolodny, Andrew. "Trends in Heroin Treatment Admissions in the United States by Race, Sex, and Age.." JAMA Network Open (2021).
  • Kolodny, Andrew. "Validation of the Opioid Overdose Risk Behavior Scale, version 2 (ORBS-2)." Drug Alcohol Depend 223. 108721 (2021).